Searchable abstracts of presentations at key conferences in endocrinology
Endocrine Abstracts (2025) 110 P1148 | DOI: 10.1530/endoabs.110.P1148

ECEESPE2025 Poster Presentations Thyroid (141 abstracts)

Risk of psychiatric disorders in patients with graves’ disease: a nationwide population-based analysis

Seo Young Sohn 1 , Jeong Heo 1 , Jiyeon Ahn 1 , Min Kyung Lee 1 , Jae Hyuk Lee 1 , Yunjin Kim 2 & Sung Woo Cho 3


1Myongji Hospital, Hanyang University College of Medicine, Division of Endocrinology, Department of Internal Medicine, Goyang, South Korea; 2Hanyang University College of Medicine, Biostatistics Lab, Medical Research Collaborating Center, Seoul, South Korea; 3Inje University Ilsan Paik Hospital, Inje University College of Medicine, Cardiology, Goyang, South Korea


JOINT1421

Background: Graves’ disease (GD) is an autoimmune hyperthyroidism and is associated with various psychiatric symptoms, such as irritability, mood changes, and insomnia. However, the epidemiological risk of psychiatric disorders among individuals with GD remains unclear. This study aimed to investigate whether a diagnosis of GD is associated with an increased incidence of various psychiatric disorders at a nationwide level.

Methods: This study was a retrospective cohort study using data from the Korean National Health Insurance Claims database. We identified 20,851 patients with newly diagnosed GD and 46,008 age- and sex-matched controls. Cox proportional hazards models were used to estimate the risk of incident psychiatric disorders in patients with GD compared to controls. We further analyzed the hazard ratios (HRs) by follow-up period (<2 years, ≥2 years) since the diagnosis of GD.

Results: Patients with GD exhibited a higher risk of developing psychiatric disorders compared to controls. The risk for incident depression (HR: 1.34, 95% CI: 1.24-1.44), bipolar disorder (HR: 1.57, 95% CI: 1.31-1.89), anxiety disorder (HR: 1.52, 95% CI: 1.43-1.63), and sleep disorder (HR: 1.44, 95% CI: 1.32-1.58) was significantly elevated. This increased risk for various psychiatric disorders, except schizophrenia, persisted even two years after the GD diagnosis. The association between GD and schizophrenia was not statistically significant.

Conclusions: This large-scale, population-based study demonstrates a significant association between GD and an increased risk of developing depression, bipolar disorder, anxiety disorder, and sleep disorder. The findings underscore the importance of long-term monitoring for psychiatric disorders in patients with GD.

Volume 110

Joint Congress of the European Society for Paediatric Endocrinology (ESPE) and the European Society of Endocrinology (ESE) 2025: Connecting Endocrinology Across the Life Course

European Society of Endocrinology 
European Society for Paediatric Endocrinology 

Browse other volumes

Article tools

My recent searches

No recent searches